Mar 01, 2018 / Chapters

Chapter 14 online-only appendixes: The Medicare prescription drug program (Part D): Status report (March 2018 report, revised June 25, 2018)

Research Areas:

Drugs, Devices, and Tests

Jan 11, 2018 / Presentations

The Medicare prescription drug program (Part D): Status report

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Private Plans

Jan 03, 2018 / Comment Letters

MedPAC comment on CMS’s proposed rule on the Medicare Advantage program (Part C) and Prescription Drug Benefit program (Part D)

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Private Plans, Quality

Nov 03, 2017 / Presentations

Biosimilars in Medicare Part D

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans

Oct 06, 2017 / Presentations

Part D exceptions and appeals

Research Areas:

Drugs, Devices, and Tests

Oct 02, 2017 / Reports

October 2017 Report to the Congress: Regional Variation in Medicare Part A, Part B, and Part D Spending and Service Use

Research Areas:

Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Regional Issues

Sep 07, 2017 / Presentations

Background on pharmacy benefit managers and specialty pharmacies

Research Areas:

Drugs, Devices, and Tests

Sep 07, 2017 / Presentations

Primer on Medicare coverage policy

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests

Jun 15, 2017 / Reports

June 2017 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Jun 15, 2017 / Press Releases

MedPAC releases June 2017 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality